Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease

被引：8

作者：

Bosanquet, N ^{[1
]}

Yeates, A

机构：

[1] Imperial Coll Sch Med, London, England

[2] Eisai Europe Ltd, London, England

来源：

PHARMACOECONOMICS | 2006年 / 24卷 / 06期

关键词：

D O I：

10.2165/00019053-200624060-00008

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：623 / 625

页数：3

共 14 条

[1] Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease [J].

Gauthier, S ;

Feldman, H ;

Hecker, J ;

Vellas, B ;

Emir, B ;

Subbiah, P .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) :347-354

[2] Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease [J].

Geldmacher, DS ;

Provenzano, G ;

McRae, T ;

Mastey, V ;

Ieni, JR .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (07) :937-944

[3] Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease [J].

Green, C ;

Picot, J ;

Loveman, E ;

Takeda, A ;

Kirby, J ;

Clegg, A .

PHARMACOECONOMICS, 2005, 23 (12) :1271-1282

[4] Predictors of time to institutionalization of patients with Alzheimer's disease: The CERAD experience .17. [J].

Heyman, A ;

Peterson, B ;

Fillenbaum, G ;

Pieper, C .

NEUROLOGY, 1997, 48 (05) :1304-1309

[5] The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease [J].

Holmes, C ;

Wilkinson, D ;

Dean, C ;

Vethanayagam, S ;

Olivieri, S ;

Langley, A ;

Pandita-Gunawardena, ND ;

Hogg, F ;

Clare, C ;

Damms, J .

NEUROLOGY, 2004, 63 (02) :214-219

[6] Cognitive disability and direct care costs for elderly people [J].

Kavanagh, S ;

Knapp, M .

BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :539-546

[7] Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease [J].

Lopez, OL ;

Becker, JT ;

Wisniewski, S ;

Saxton, J ;

Kaufer, DI ;

Dekosky, ST .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (03) :310-314

[8]

LOVEMAN E, TECHNOLOGY ASSESSMEN

[9]

LOVEMAN E, 2004, TECHNOLOGY ASSESSMEN

[10] A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients [J].

Mohs, RC ;

Doody, RS ;

Morris, JC ;

Ieni, JR ;

Rogers, SL ;

Perdomo, CA ;

Pratt, RD .

NEUROLOGY, 2001, 57 (03) :481-488

← 1 2 →